Results 101 to 110 of about 4,078 (132)

Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses. [PDF]

open access: yesEJNMMI Res
Engbers PAM   +6 more
europepmc   +1 more source

Radioligand therapy for primary brain tumors: a PRISMA-based systematic review of meningiomas and gliomas. [PDF]

open access: yesFront Med (Lausanne)
Grassi I   +15 more
europepmc   +1 more source

Pancreatic Neuroendocrine Tumors: From Benchside to Surgical Treatment. [PDF]

open access: yesMedicina (Kaunas)
Conzo G   +9 more
europepmc   +1 more source

Targeted β<sup>-</sup>-Particle Plus Conversion and Auger-Electron Therapy with <sup>161</sup>Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study. [PDF]

open access: yesJ Nucl Med
Fricke JG   +14 more
europepmc   +1 more source

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial. [PDF]

open access: yesFront Endocrinol (Lausanne)
Kolodziej M   +29 more
europepmc   +1 more source

Intra-Arterial Radioligand Therapy in Brain Cancer: Bridging Nuclear Medicine and Interventional Neuroradiology. [PDF]

open access: yesDiagnostics (Basel)
Sabuzi F   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy